Edwards Lifesciences
428 hedge funds and large institutions have $8.09B invested in Edwards Lifesciences in 2014 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 96 increasing their positions, 177 reducing their positions, and 45 closing their positions.
49% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 45
12% more capital invested
Capital invested by funds: $7.25B → $8.09B (+$838M)
5% more funds holding
Funds holding: 409 → 428 (+19)
9% more call options, than puts
Call options by funds: $44.5M | Put options by funds: $40.9M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
11.23% less ownership
Funds ownership: 547.24% → 536.01% (-11%)
46% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 177
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$153M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$60.8M |
| 3 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$48.8M |
| 4 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
+$42.2M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$29.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$203M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$126M |
| 3 |
CCM
Cornerstone Capital Management
Edina,
Minnesota
|
-$90.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$76.1M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$45.4M |
EW Hedge Fund Activity: Q2 2014 in Review
428 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2014, worth a combined $8.09B — up 12% from $7.25B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new EW positions and 45 closed out — a net gain of 22 holders — while 96 added to existing stakes and 177 trimmed.
The largest buyer was Generation Investment Management, adding an estimated $153M. The largest seller was Capital Research Global Investors, cutting an estimated $203M.
- 428 institutional investors held Edwards Lifesciences (EW) as of Q2 2014, up from 409 in Q1 2014.
- Funds reported $8.09B of Edwards Lifesciences stock for Q2 2014, up 12% quarter-over-quarter.
- 67 funds opened new Edwards Lifesciences positions in Q2 2014 and 45 closed out, a net change of +22 holders.
- The largest Edwards Lifesciences buyer in Q2 2014 was Generation Investment Management, an estimated $153M added.
- The largest Edwards Lifesciences seller in Q2 2014 was Capital Research Global Investors, an estimated $203M sold.
Based on aggregated 13F filings for Q2 2014.